"Chromosome Deletion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Actual loss of portion of a chromosome.
Descriptor ID |
D002872
|
MeSH Number(s) |
C23.550.210.050.500.500 G05.365.590.029.530.175 G05.365.590.175.050.500.500 G05.365.590.762.180 G05.558.800.180 G05.700.131.500.500
|
Concept/Terms |
Partial Monosomy- Partial Monosomy
- Monosomies, Partial
- Partial Monosomies
- Monosomy, Partial
|
Below are MeSH descriptors whose meaning is more general than "Chromosome Deletion".
Below are MeSH descriptors whose meaning is more specific than "Chromosome Deletion".
This graph shows the total number of publications written about "Chromosome Deletion" by people in this website by year, and whether "Chromosome Deletion" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 8 | 5 | 13 |
1995 | 11 | 5 | 16 |
1996 | 4 | 3 | 7 |
1997 | 14 | 1 | 15 |
1998 | 8 | 6 | 14 |
1999 | 7 | 3 | 10 |
2000 | 8 | 5 | 13 |
2001 | 4 | 3 | 7 |
2002 | 2 | 6 | 8 |
2003 | 8 | 6 | 14 |
2004 | 7 | 5 | 12 |
2005 | 9 | 6 | 15 |
2006 | 4 | 4 | 8 |
2007 | 12 | 4 | 16 |
2008 | 12 | 5 | 17 |
2009 | 19 | 10 | 29 |
2010 | 16 | 9 | 25 |
2011 | 12 | 16 | 28 |
2012 | 13 | 11 | 24 |
2013 | 11 | 7 | 18 |
2014 | 8 | 7 | 15 |
2015 | 11 | 12 | 23 |
2016 | 9 | 12 | 21 |
2017 | 6 | 4 | 10 |
2018 | 6 | 8 | 14 |
2019 | 2 | 6 | 8 |
2020 | 4 | 5 | 9 |
2021 | 3 | 8 | 11 |
2022 | 0 | 2 | 2 |
2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chromosome Deletion" by people in Profiles.
-
Clinical exome sequencing efficacy and phenotypic expansions involving anomalous pulmonary venous return. Eur J Hum Genet. 2023 12; 31(12):1430-1439.
-
Clinical characteristics and overall survival among acute myeloid leukemia patients with TP53 gene mutation or chromosome 17p deletion. Am J Hematol. 2023 08; 98(8):1176-1184.
-
Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. J Clin Immunol. 2023 02; 43(2):247-270.
-
Koolen-de Vries syndrome associated with continuous spike-wave in sleep Epileptic Disord. 2022 10 01; 24(5):928-933.
-
Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of TP53 alterations and venetoclax treatment. Leuk Lymphoma. 2022 12; 63(13):3105-3116.
-
Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality. Science. 2022 07 15; 377(6603):292-297.
-
Hospital Outcomes Among Infants With Interrupted Aortic Arch With Simple and Complex Associated Heart Defects. Am J Cardiol. 2022 03 01; 166:97-106.
-
Ibrutinib induces durable remissions in treatment-na?ve patients with CLL and 17p deletion and/or TP53 mutations. Blood. 2021 12 16; 138(24):2589-2592.
-
Translational pediatrics: clinical perspective for Phelan-McDermid syndrome and autism research. Pediatr Res. 2022 08; 92(2):373-377.
-
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy. Nat Commun. 2021 10 18; 12(1):6071.